For full article just copy and paste the title in google. Skin...

For full article just copy and paste the title in google.

Skin in the game: The ASX share in my portfolio I’m most excited about
Our Foolish writers spill the tea on the shares they own and have the highest hopes for.


According to Oxford Languages, ‘motley’ means “incongruously varied in appearance or character”. But in relation to our Foolish writers, it means they vary greatly with regard to age, risk tolerance, and stage of life as well as investing budget, timeframe, and expectations.

Despite their many differences, a passion for investing in ASX shares is something all our writers definitely have in common.

So when we asked them to let us know which of the ASX companies they own shares in that they are feeling particularly upbeat about right now, they leapt at the chance to share their thoughts.

Here’s what they had to say:

8 of their own ASX shares our writers are especially pumped about (smallest to largest)

• Bailador Technology Investments Ltd(ASX: BTI), $185.59 million
• Alcidion Group Ltd (ASX: ALC), $199.72 million
• VanEck Morningstar Wide Moat ETF(ASX: MOAT), $454.32 million
• Vulcan Energy Resources Ltd (ASX: VUL), $1.01 billion
• Elders Ltd (ASX: ELD), $1.59 billion
• Telix Pharmaceuticals Ltd (ASX: TLX), $2.324 billion
• Domino’s Pizza Enterprises Ltd (ASX: DMP), $5.70 billion
• Fortescue Metals Group Limited(ASX: FMG), $58.32 billion

(Market capitalisations as of market close on 25 November 2022)

Why these ASX shares set our writers’ hearts aflutter

Alcidion Group Ltd
What it does: Alcidion is a healthcare informatics company that provides a range of software solutions to hospitals and healthcare professionals. Think everything from patient flow and bed management to real-time analytics, theatre management, waiting lists, and registrations.

Alcidion has an established foothold in Australia, New Zealand, and the United Kingdom, with its technology being used to manage more than 65,000 beds across 400 hospitals.

"); background-origin: content-box; background-size: 9px 6px; transition: box-shadow 0.5s ease 0s, border-color 0.25s ease-in-out 0s, -webkit-box-shadow 0.5s ease 0s; position: absolute; top: 10.5px; cursor: pointer; opacity: 0.0001; left: 10px; background-position: right -1rem center; background-repeat: no-repeat no-repeat;">Zoom1M3M6MYTD1Y5Y10YALL
Jan '22Apr '22Jul '22Oct '22Jan '22Jul '220.10.20.3Zoom ▾Dec 1, 2021→Nov 30, 2022Highcharts.com
By Cathryn Goh: Although the digital transformation of business, in general, has been in train for some time, the healthcare sector has been somewhat of a laggard. Many hospitals are rooted in old-world systems. Others have embraced digital but use a variety of disparate systems that don’t talk to each other.

This is where Alcidion enters the fray, offering hospitals everything from a fully-fledged electronic patient record (EPR) solution to individual software modules that play nice with existing technology investments.

Put simply, Alcidion is a mission-critical, scalable software business that’s experiencing strong business momentum and has tipped into cash flow and earnings before interest, tax, depreciation and amortisation (EBITDA) positive territory.

With a newly-transformed offering and stiff industry tailwinds at its back, it’s a small-cap ASX share I think holds plenty of promise.

Motley Fool contributor Cathryn Goh owns shares in Alcidion Group Ltd.